The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has jumped 180% in a year, to $0.3226 per unit — sharp rises like this often mean supply is already tightening. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.